Package 0069-8141-20

{"route": ["ORAL"], "spl_id": "f5e01d3a-43fc-4fa6-b5dd-a07330b49328", "openfda": {"nui": ["N0000175605", "N0000190114", "N0000020000", "N0000182139", "N0000185503", "N0000191265", "N0000187061"], "upc": ["0300698140201", "0300690507606", "0300690251608", "0300691500606", "0300698141208"], "unii": ["53AH36668S"], "rxcui": ["1148498", "1148502", "1148504", "1148506", "2670166", "2670170", "2670172", "2670174", "2670176", "2670178"], "spl_set_id": ["2a51b0de-47d6-455e-a94c-d2c737b04ff7"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "Receptor Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Organic Cation Transporter 1 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (0069-8141-20)", "package_ndc": "0069-8141-20", "marketing_start_date": "20110826"}], "brand_name": "Xalkori", "product_id": "0069-8141_f5e01d3a-43fc-4fa6-b5dd-a07330b49328", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Organic Cation Transporter 1 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Receptor Tyrosine Kinase Inhibitors [MoA]"], "product_ndc": "0069-8141", "generic_name": "CRIZOTINIB", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Xalkori", "active_ingredients": [{"name": "CRIZOTINIB", "strength": "200 mg/1"}], "application_number": "NDA202570", "marketing_category": "NDA", "marketing_start_date": "20110826", "listing_expiration_date": "20261231"}